NCT02853136View on ClinicalTrials.gov

Influence of Fluvoxamine on the Pharmacokinetics of BI 409306

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 25, 2016

Primary Completion Date

October 17, 2016

Study Completion Date

October 25, 2016

Conditions
Healthy
Interventions
DRUG

Fluvoxamine

Fluvoxamine

DRUG

BI 409306 - Powder for oral solution (PfOS)

BI 409306 - Powder for oral solution (PfOS)

DRUG

BI 409306 - film coated tablet

BI 409306 - film coated tablet

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY